University of Rochester NCORP Research Base
11
0
6
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 30/100
9.1%
1 terminated/withdrawn out of 11 trials
80.0%
-6.5% vs industry average
27%
3 trials in Phase 3/4
100%
4 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Comparing Brief Behavioral Therapy (BBT-CI) and Healthy Eating Education Learning (HEAL) for Cancer-Related Sleep Problems While Receiving Cancer Treatment
Role: lead
Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy
Role: lead
Testing the Effects of Exercise on Chemotherapy-Induced Peripheral Neuropathy
Role: lead
An Observational Research Study for Cancer Patients on Immune Checkpoint Inhibitors, DiRECT Study
Role: lead
Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors
Role: lead
Learning Collaborative Versus Technical Assistance in Delivering a Palliative Care Program to Patients With Advanced Cancer and Their Caregivers
Role: lead
Treatment of Refractory Nausea and Vomiting in Patients With Breast Cancer
Role: lead
Understanding the Impact of Drug Shortages on Oncology Care Delivery
Role: lead
Yoga, Survivorship Health Education, and Cognitive Behavioral Therapy in Reducing Insomnia in Cancer Survivors
Role: lead
Low-Dose Ibuprofen in Improving Cognitive Impairment in Patients With Cancer
Role: lead
Effects of Transcutaneous Electrical Nerve Stimulation on Chemotherapy-Induced Peripheral Neuropathy
Role: lead
All 11 trials loaded